Clinical Trial Equipment & Ancillary Solutions Market growth is driven by the increasing complexity and globalization of clinical trials, technological advancements, and a rising focus on patient-centric study designs
Austin, Nov. 17, 2025 (GLOBE NEWSWIRE) — According to SNS Insider, The Clinical Trial Equipment & Ancillary Solutions Market size was valued at USD 2.23 billion in 2023 and is expected to reach USD 4.39 billion by 2032, growing at a CAGR of 7.84% during 2024-2032. Market growth is supported by increasing global trial volume, higher R&D spending, and the rapid advancement of therapeutic modalities that require specialized equipment and supply chain systems.
Get a Sample Report of Clinical Trial Equipment & Ancillary Solutions Market Forecast: https://www.snsinsider.com/sample-request/6038
Rising Advancements in Trial Methodologies and R&D Investments Boost Market Growth Globally
Specialized trial equipment and related materials are in greater demand as a result of the growing demand for precision medicine, biologics, and cell and gene treatments. As of 2023, over 450,000 clinical trials were registered, according to ClinicalTrials.gov, demonstrating a strong market need. The usage of digital data gathering tools, direct-to-patient (DTP) logistical solutions, and remote monitoring devices has increased due to the tendency toward decentralized and hybrid trials.
Additionally, the market is being driven by the growing tendency of pharmaceutical corporations outsourcing to Contract Research Organizations (CROs), since these organizations require efficient supply chain and equipment solutions. Sophisticated cold chain logistics and storage solutions are in greater demand as a result of growing regulatory requirements for temperature-sensitive biologics. Operational efficiency has increased with the introduction of blockchain technology and AI-based clinical trial management solutions for the safe handling of trial data.
Segmentation Analysis:
By Product
The logistics/supply segment dominated with a share of 39.2% in total revenue in 2023 as the clinical trials are becoming increasingly complex and need effective supply chain management for on-time delivery of trial machinery, biological samples, and temperature-sensitive products. The sourcing segment is projected to see the most robust growth up to 2032, led by growing dependence on expert suppliers for clinical trial hardware and ancillary solutions.
By Phase
The Phase III segment dominated the market in 2023, with the largest share based on the massive resource needs and extensive patient recruitment of this stage of clinical trials. The Phase I segment is also expected to develop at the fastest rate during the forecast period due to the growth in early-stage trials, especially in precision medicine, biologics, and gene therapies.
Regional Insights:
North America led the clinical trial equipment & ancillary solutions market in 2023, with a 40.05% revenue share. The region’s growth is attributed to a well-established pharmaceutical and biotechnology industry, high R&D spending, and a large number of clinical trial activities.
Asia Pacific is expected to be the fastest-growing region until 2032, led by the growing number of clinical trials, growing pharmaceutical outsourcing, and increasing healthcare infrastructure.
Purchase Single User PDF of Clinical Trial Equipment & Ancillary Solutions Market Report: https://www.snsinsider.com/checkout/6038
Major Players Analysis Listed in the Clinical Trial Equipment & Ancillary Solutions Market Report are
- Ancillare, LP – Clinical Trial Ancillary Supply Chain Solutions, Trial Equipment & Logistics Services
- Imperial CRS, Inc. – Ancillary Supplies Management, Trial Logistics & Storage Solutions
- Woodley Equipment Company Ltd. – Medical & Laboratory Equipment Rental, Temperature-Controlled Storage Solutions
- Thermo Fisher Scientific, Inc. – Clinical Trial Equipment & Lab Instruments, Cold Chain Logistics & Packaging
- Parexel International (MA) Corporation – Clinical Trial Supply & Logistics Services, Medical Device & Equipment Management
- Emsere (formerly MediCapital Rent) – Clinical Trial Equipment Rental & Leasing, Site-Specific Equipment Solutions
- Quipment SAS – Equipment Rental & Calibration Services, Remote Monitoring Devices
- IRM (International Resource Management) – Clinical Trial Supply Chain Management, Equipment & Ancillary Solutions
- Marken – Clinical Trial Logistics & Distribution, Temperature-Controlled Supply Chain Solutions
- Myonex – Clinical Trial Drug & Equipment Supply, Global Site Equipment Management
- Yourway – Direct-to-Patient (DTP) Logistics, Clinical Trial Supply Chain & Ancillary Services
Recent Developments:
- In Jan 2025, Ancillare launched its advanced Cold Chain Management services to enhance the safe handling and transport of temperature-sensitive clinical trial supplies. This fully integrated solution ensures optimal product conditions while complying with stringent global regulatory standards.
- In March 2024, Myonex announced the acquisition of Creapharm’s Clinical & Commercial Packaging and Bioservices business, expanding its global footprint. The deal includes operations in France (Reims, Bordeaux, Bailly-Romainvilliers) and Marietta, Georgia, U.S., strengthening Myonex’s clinical trial supply capabilities.
Exclusive Sections of the Report (The USPs):
- CLINICAL TRIAL ACTIVITY METRICS – helps you analyze the global growth trajectory and incidence of clinical trials, offering insights into therapeutic areas and geographies driving the highest trial volumes.
- REGIONAL EQUIPMENT DEMAND INDEX – helps you identify regional hotspots with rising demand for clinical trial equipment and ancillary solutions, aiding in market entry and expansion strategies.
- FUNDING & SPENDING LANDSCAPE – helps you understand capital allocation patterns from government bodies, CROs, and private investors shaping equipment procurement and infrastructure investments.
- REGULATORY & COMPLIANCE BENCHMARKS – helps you assess evolving clinical trial regulations, equipment validation standards, and compliance mandates impacting market participants globally.
- DIGITAL TRANSFORMATION & TECHNOLOGY ADOPTION RATE – helps you uncover advancements such as IoT-enabled monitoring devices, remote trial equipment, and automation technologies transforming clinical trial efficiency.
Do you have any specific queries or need any customized research on Clinical Trial Equipment & Ancillary Solutions Market? Submit your inquiry here: https://www.snsinsider.com/enquiry/6038
Clinical Trial Equipment & Ancillary Solutions Market Report Scope
| Report Attributes | Details |
| Market Size in 2023 | USD 2.23 billion |
| Market Size by 2032 | USD 4.39 billion |
| CAGR | CAGR of 7.84% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Key Segments | • By Product [Sourcing (Procurement, Rental), Supply/Logistics (Transportation, Packaging, Others), Service (Calibrations, Equipment servicing, Others), Others]
• By Phase [Phase I, Phase II, Phase III, Phase IV] |
| Regional Analysis/Coverage | North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Russia, Poland, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN Countries, Rest of Asia Pacific), Middle East & Africa (UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Mexico, Colombia, Rest of Latin America). |
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company’s aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
CONTACT: Contact Us: Rohan Jadhav - Principal Consultant Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK) Email: info@snsinsider.com
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.